BCBA/ABT (BCBA/ABT)

Buenos Aires Stock Exchange: BCBA/ABT · ARS

ARS 42,600

+260.00 (+0.6%)· Recorded snapshot

Market cap	273.1T
Revenue (ttm)	73.5T
Net income (ttm)	7.1T
EPS (ttm)	ARS 1,037
P/E (trailing)	41.1x
P/E (forward)	17.5x
Dividend	ARS 666 (1.56%)
Volume	851

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 73.5T
Net income (ttm): 7.1T
EPS (ttm): ARS 1,037
P/E (trailing): 41.1x
P/E (forward): 17.5x
Market cap: 273.1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E17.5

P25 n/aP50 n/aP75 n/a

Trailing P/E41.1

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/ABT indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-21
Employees	122,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	ARS 315.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	ARDEUT110608
Last earnings date	2026-10-21
Last refreshed	2026-10-29
Last stock split date	2020-10-22
Last stock split type	Forward
Market cap	ARS 273.1T
Price	ARS 42,600.00
Price currency	ARS
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	bcba/ABT
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.43%
EV/Earnings	44.27x
EV/EBIT	25.73x
EV/EBITDA	16.64x
EV/FCF	26.18x
EV/Sales	4.26x
FCF / EV yield	3.82%
FCF yield	4.42%
Forward P/E	17.47x
Graham number	17558.42665
Graham upside	-58.78%
Lynch fair value	ARS 5,563.43
Lynch upside	-86.94%
P/(FCF - SBC) ratio	24.92x
P/(OCF - SBC) ratio	19.28x
P/B ratio	3.46x
P/E ratio	41.08x
P/FCF ratio	22.64x
P/OCF ratio	17.88x
P/S ratio	3.71x
Price/EBITDA ratio	14.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	ARS 62M
Profitable quarters	34
Profitable years	35
Revenue per employee	ARS 639.5M
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	11
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -3.2T
Depreciation and amortization	ARS 6.1T
EBIT	ARS 12.2T
EBITDA	ARS 18.2T
EPS	ARS 1,037.06
Financing cash flow	ARS 16.4T
Free cash flow	ARS 12.1T
Free cash flow minus SBC	ARS 11T
Gross profit	ARS 42T
Income taxes	ARS 2.8T
Investing cash flow	ARS -34.5T
Net borrowing	ARS 25.5T
Net cash flow	ARS -2.8T
Net income	ARS 7.1T
Operating cash flow minus SBC	ARS 14.2T
Operating income	ARS 12.2T
Revenue	ARS 73.5T
Stock-based compensation	ARS 1.1T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	ARS 45,040.68
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.14
Interest coverage	7.87
Net cash (debt)	ARS -41.4T
Net cash / market cap	-15.14%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.43
Piotroski F-Score	5
Shareholders' equity	ARS 78.9T
Tangible book value	ARS -2.1T
Tangible book value per share	ARS -1,185.28
Total cash	ARS 8.5T
Total debt	ARS 49.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	ARS 10.3T

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	47.34%
Dividend growth (10Y)	76.1%
Dividend growth (3Y)	89.59%
Dividend growth (5Y)	91.48%
Dividend growth years	12
Dividend payment date	2026-11-16
Dividend payment years	27
Dividend payout frequency	Quarterly
Dividend per share	ARS 666.10
Dividend yield	1.56%
Ex-dividend date	2026-10-15
Last dividend	ARS 238.47
Payout ratio	64.4%
Shareholder yield	1.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	27,769.01%
10Y return CAGR	77.42%
10Y total return	30,774.38%
150-day SMA	ARS 38,296.00
15Y price change	65,773.2%
15Y return CAGR	55.78%
15Y total return	77,109.56%
1D price change	0.61%
1M price change	3.42%
1M total return	4.02%
1W price change	0.91%
1W total return	0.91%
1Y price change	-14.5%
1Y return CAGR	-13.07%
1Y total return	-13.06%
20-day SMA	ARS 41,193.00
200-day SMA	ARS 39,350.60
20Y price change	113,870.39%
20Y return CAGR	43.46%
20Y total return	136,285.64%
3M price change	2.82%
3M total return	3.41%
3Y price change	103.56%
3Y return CAGR	28.3%
3Y total return	111.23%
50-day SMA	ARS 42,232.00
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 52,000.00
52-week high date	2025-10-27
52-week low	ARS 30,380.00
52-week low date	2026-05-11
5Y price change	556.43%
5Y return CAGR	47.13%
5Y total return	589.3%
6M price change	24.09%
6M total return	25.34%
All-time high	ARS 53,525.00
All-time high date	2025-09-19
All-time low	ARS 10.55
All-time low date	2000-09-12
Average true range (ATR)	ARS 1,187.19
Average volume	2.2K
Change from 52-week high	-18.08%
Change from 52-week low	40.22%
Change from all-time high	-20.9%
Change from all-time low	401,227.01%
Change from open	-0.23%
Day's gap	0.85%
Dollar volume	ARS 36.3M
High price	ARS 42,940.00
Low price	ARS 41,980.00
Monthly RSI	55.36
Open price	ARS 42,700.00
Position in 52-week range	64.58%
Previous close	ARS 42,340.00
Price vs 150-day SMA	10.56%
Price vs 20-day SMA	2.78%
Price vs 200-day SMA	7.6%
Price vs 50-day SMA	0.26%
Relative volume	0.39
RSI	53.93
Sharpe ratio	-0.27
Sharpe ratio (3Y)	0.86
Sharpe ratio (5Y)	1.22
Sortino ratio	-0.2
Sortino ratio (3Y)	1.45
Sortino ratio (5Y)	2.04
Volume	851
Weekly RSI	55.03
YTD price change	-11.39%
YTD total return	-9.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.5%
Shares held by institutions	80.99%
Short ratio	1.9 days

Deeper analysis on BCBA/ABT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/ABT report

Is a complete BCBA/ABT research report available?

No complete published report is available for bcba/ABT (BCBA/ABT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/ABT (BCBA/ABT)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ABT

Frequently asked questions